Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gengmei is a Chinese consumer healthcare and medical aesthetics platform focused on connecting users with aesthetic medicine services, physicians, clinics, and related content. Its flagship Gengmei App offers medical aesthetics community features, doctor and hospital discovery, consultation, AI-enabled facial analysis, video consultation, and e-commerce-style booking and payment tools for procedures such as plastic surgery, minimally invasive aesthetics, dental care, ophthalmology, and anti-aging services. The company appears to operate primarily as a commercial healthtech marketplace and service platform rather than a drug developer. It generates value by aggregating demand, providing decision-support and safety-oriented information for consumers, and offering branding and customer acquisition tools for doctors and institutions. For a biotech analyst, Gengmei is best understood as a digital health/consumer medical platform within China's aesthetic healthcare ecosystem, not as a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gengmei.